Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
주식 순위 #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
주가
$0.00060315
마지막 동기화: 2024-09-27
시가총액
$1.65M
변동 (1일)
19.64%
변동 (1년)
0.00%
국가
SE
거래 Amniotics AB (publ) (AMNI)

카테고리

Amniotics AB (publ) (AMNI)의 EPS
December 2023 기준 EPS TTM: $-0.04
Amniotics AB (publ)의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.04입니다. 2022년 말에는 회사의 EPS가 $-0.03였으며, 이는 2021년의 EPS $-0.04와 감소입니다.
Amniotics AB (publ)의 EPS 기록 (2018 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -47,293.46%
US
$27.74 -75,685.83%
NL
- -
CH
- -
KR
$13.70 -37,429.97%
BE